CD16-158-Valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to CetuximabRoberto Arriga, Giuseppe Sconocchia|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 3